Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer
© 2024. The Author(s)..
To evaluate the role of chemotherapy in stage IA triple-negative breast cancer, we conducted a retrospective population-based study including 8601 patients. The use of chemotherapy significantly increased from 2010 to 2019 in patients with T1b and T1c tumors (p = 0.001 and p < 0.001, respectively). Receipt of chemotherapy was associated with improved breast cancer-specific survival (BCSS, adjusted hazard ratio = 0.70; p = 0.006), particularly in patients with T1c tumors (5-year BCSS 94.5% vs. 91.2%).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
NPJ breast cancer - 10(2024), 1 vom: 04. Apr., Seite 26 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tarantino, Paolo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 07.04.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1038/s41523-024-00634-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370651111 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370651111 | ||
| 003 | DE-627 | ||
| 005 | 20240407232450.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240405s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41523-024-00634-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1368.xml |
| 035 | |a (DE-627)NLM370651111 | ||
| 035 | |a (NLM)38575691 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tarantino, Paolo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 07.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a To evaluate the role of chemotherapy in stage IA triple-negative breast cancer, we conducted a retrospective population-based study including 8601 patients. The use of chemotherapy significantly increased from 2010 to 2019 in patients with T1b and T1c tumors (p = 0.001 and p < 0.001, respectively). Receipt of chemotherapy was associated with improved breast cancer-specific survival (BCSS, adjusted hazard ratio = 0.70; p = 0.006), particularly in patients with T1c tumors (5-year BCSS 94.5% vs. 91.2%) | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Leone, Julieta |e verfasserin |4 aut | |
| 700 | 1 | |a Vallejo, Carlos T |e verfasserin |4 aut | |
| 700 | 1 | |a Freedman, Rachel A |e verfasserin |4 aut | |
| 700 | 1 | |a Waks, Adrienne G |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Sáez, Olga |e verfasserin |4 aut | |
| 700 | 1 | |a Garrido-Castro, Ana |e verfasserin |4 aut | |
| 700 | 1 | |a Lynce, Filipa |e verfasserin |4 aut | |
| 700 | 1 | |a Tayob, Nabihah |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Nancy U |e verfasserin |4 aut | |
| 700 | 1 | |a Tolaney, Sara M |e verfasserin |4 aut | |
| 700 | 1 | |a Leone, Jose P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t NPJ breast cancer |d 2015 |g 10(2024), 1 vom: 04. Apr., Seite 26 |w (DE-627)NLM256806586 |x 2374-4677 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2024 |g number:1 |g day:04 |g month:04 |g pages:26 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41523-024-00634-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2024 |e 1 |b 04 |c 04 |h 26 | ||